|
If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||||||||
  Clinical TransplantationVolume 20 Issue 1, Pages 136 - 138 Published Online: 1 Sep 2005 © 2010 John Wiley & Sons A/S
Abstract | References | Full Text: HTML, PDF (Size: 75K) | Related Articles | Citation Tracking  Case Report Fulminating varicella despite prophylactic immune globulin and intravenous acyclovir in a renal transplant recipient: should renal patients be vaccinated against VZV before transplantation? Copyright 2005 Blackwell Munksgaard KEYWORDS varicella zoster virus • chronic kidney disease • renal transplantation Robertson S, Newbigging K, Carman W, Jones G, Isles C on behalf of the Scottish Renal Registry. Fulminating varicella despite prophylactic immune globulin and intravenous acyclovir in a renal transplant recipient: should renal patients be vaccinated against VZV before transplantation?
Clin Transplant 2005 DOI: 10.1111/j.1399-0012.2005.00435.x © Blackwell Munksgaard, 2005 ABSTRACTAbstract: We describe a case of fulminating varicella despite prophylactic immune globulin and intravenous acyclovir in a renal transplant recipient. This promoted a survey of all 383 adult patients awaiting a renal transplant in Scotland, which showed a low level of Varicella zoster virus (VZV) awareness but a willingness to consider vaccination if non immune. 359/363 serum samples tested were seropositive for VZV antibody giving a susceptibility to VZV of 1.2%. Although data on vaccination in adults with chronic kidney disease are limited, expert opinion is of the view that the benefits of vaccinating immunocompetent seronegative patients before transplantation are likely to outweigh the risks. We believe that adult patients awaiting a transplant in the UK should be tested for their susceptibility to VZV and that early vaccination should be offered to those who are both immunocompetent and seronegative. Accepted for publication 13 July 2005 | 
|
